Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients

Johan De Sutter(Ghent University Hospital), Guy De Backer(Ghent University), René Tavernier(AZ Sint-Jan), Luc Jordaens(Erasmus MC), Marc De Buyzere(Ghent University Hospital)

Journal of the American College of Cardiology

September 1, 2000

10.1016/s0735-1097(00)00787-7

Cited by 121

Related Papers

ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

|European Heart Journal|2011|3.5k

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

|European Heart Journal|2016|3.2k

American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy

|Journal of the American College of Cardiology|2003|1.6k

Improving procedural and one-year outcome after contact force-guided pulmonary vein isolation: the role of interlesion distance, ablation index, and contact force variability in the ‘CLOSE’-protocol

|EP Europace|2018|358

Evaluation of a Strategy Aiming to Enclose the Pulmonary Veins With Contiguous and Optimized Radiofrequency Lesions in Paroxysmal Atrial Fibrillation

|JACC. Clinical electrophysiology|2017|347